Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Drug safety [[electronic resource] ] : FDA faces challenges overseeing the foreign drug manufacturing supply chain : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate / / statement of Marcia Crosse
| Drug safety [[electronic resource] ] : FDA faces challenges overseeing the foreign drug manufacturing supply chain : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate / / statement of Marcia Crosse |
| Autore | Crosse Marcia |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2011] |
| Descrizione fisica | 1 online resource (15 pages) |
| Collana | Testimony |
| Soggetto topico |
Drugs - Safety measures
Drugs - Safety measures - Government policy - United States |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910701237703321 |
Crosse Marcia
|
||
| [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2011] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety [[electronic resource] ] : preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
| Drug safety [[electronic resource] ] : preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse |
| Autore | Crosse Marcia |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2008] |
| Descrizione fisica | 19 pages : digital, PDF file |
| Collana | Testimony |
| Soggetto topico |
Drugs - Safety measures
Drugs - Inspection |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910696615703321 |
|
Crosse Marcia
|
||
| [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2008] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety [[electronic resource] ] : preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
| Drug safety [[electronic resource] ] : preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse |
| Autore | Crosse Marcia |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007] |
| Descrizione fisica | 24 pages : digital, PDF file |
| Collana | Testimony |
| Soggetto topico |
Drugs - Safety measures
Drugs - Inspection |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910696397103321 |
|
Crosse Marcia
|
||
| [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety [[electronic resource] ] : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
| Drug safety [[electronic resource] ] : further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse |
| Autore | Crosse Marcia |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007] |
| Descrizione fisica | 13 pages : digital, PDF file |
| Collana | Testimony |
| Soggetto topico |
Drugs - Safety measures
Drugs - Safety measures - Government policy - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910695979303321 |
|
Crosse Marcia
|
||
| [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety [[electronic resource] ] : FDA needs to further address shortcomings in its postmarket decision-making process : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse
| Drug safety [[electronic resource] ] : FDA needs to further address shortcomings in its postmarket decision-making process : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives / / statement of Marcia Crosse |
| Autore | Crosse Marcia |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007] |
| Descrizione fisica | 13 pages : digital, PDF file |
| Collana | Testimony |
| Soggetto topico | Drugs - United States - Safety measures |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910695713003321 |
|
Crosse Marcia
|
||
| [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2007] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010
| Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Printing Office, , 2012 |
| Descrizione fisica | 1 online resource (v, 81 pages) |
| Soggetto topico |
Drugs - Safety regulations - United States
Pharmaceutical policy - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910704334103321 |
| Washington : , : U.S. Government Printing Office, , 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety [[electronic resource] ] : FDA has conducted more foreign inspections and begun to improve its information on foreign establishments, but more progress is needed : report to the Committee on Oversight and Government Reform, House of Representatives
| Drug safety [[electronic resource] ] : FDA has conducted more foreign inspections and begun to improve its information on foreign establishments, but more progress is needed : report to the Committee on Oversight and Government Reform, House of Representatives |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2010] |
| Descrizione fisica | 1 online resource (ii, 38 pages) : illustrations |
| Soggetto topico |
Drugs - United States - Safety measures
Imports - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910700553603321 |
| [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2010] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety [[electronic resource] ] : FDA has begun efforts to enhance postmarket safety, but additional actions are needed : report to the Ranking Member, Committee on Finance, U.S. Senate
| Drug safety [[electronic resource] ] : FDA has begun efforts to enhance postmarket safety, but additional actions are needed : report to the Ranking Member, Committee on Finance, U.S. Senate |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2009] |
| Descrizione fisica | 1 online resource (ii, 48 pages) : illustrations |
| Soggetto topico | Drugs - United States - Safety measures |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910697088803321 |
| [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2009] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety [[electronic resource] ] : better data management and more inspections are needed to strengthen FDA's foreign drug inspection program : report to congressional requesters
| Drug safety [[electronic resource] ] : better data management and more inspections are needed to strengthen FDA's foreign drug inspection program : report to congressional requesters |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2008] |
| Descrizione fisica | ii, 53 pages : digital, PDF file |
| Soggetto topico |
Drugs - Safety measures
Pharmaceutical industry - Foreign countries |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910697853703321 |
| [Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2008] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug safety [[electronic resource] ] : improvement needed in FDA's postmarket decision-making and oversight process : report to congressional requesters
| Drug safety [[electronic resource] ] : improvement needed in FDA's postmarket decision-making and oversight process : report to congressional requesters |
| Pubbl/distr/stampa | [Washington, D.C.] : , : U.S. Government Accountability Office, , [2006] |
| Descrizione fisica | ii, 62 pages : digital, PDF file |
| Soggetto topico | Drugs - United States - Safety measures |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Drug safety |
| Record Nr. | UNINA-9910695172003321 |
| [Washington, D.C.] : , : U.S. Government Accountability Office, , [2006] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
